Abstract
The balance between T helper cell subsets is an important regulator of the immune system and is often examined after immune therapies. We aimed to study the immunomodulatory effect of glutamic acid decarboxylase (GAD) 65 formulated with aluminium hydroxide (GAD-alum) in children with Type 1 diabetes, focusing on chemokines and their receptors. Blood samples were collected from 70 children with Type 1 diabetes included in a phase II clinical trial with GAD-alum. Expression of CC chemokine receptor 5 (CCR5) and CCR4 was analysed on CD4+ and CD8+ lymphocytes after in vitro stimulation with GAD(65) using flow cytometry, and secretion of the chemokines CCL2, CCL3 and CCL4 was detected in peripheral blood mononuclear cell supernatants with Luminex. Expression of Th1-associated CCR5 was down-regulated following antigen challenge, together with an increased CCR4/CCR5 ratio and CCL2 secretion in GAD-alum-treated patients, but not in the placebo group. Our results suggest that GAD-alum treatment has induced a favourable immune modulation associated with decreased Th1/Tc1 phenotypes upon antigen re-challenge, which may be of importance for regulating GAD(65) immunity.
References
Oct 11, 1991·Science·P SalgameB R Bloom
Oct 1, 1991·The Journal of Pathology·A K FoulisM A Farquharson
Nov 1, 1994·The Journal of Experimental Medicine·M CroftR W Dutton
Mar 1, 1995·Immunity·S SadT R Mosmann
Aug 1, 1994·The Journal of Experimental Medicine·E MaggiS Romagnani
Jun 18, 1993·Science·F ErardG Le Gros
Mar 28, 1998·The Journal of Experimental Medicine·W J KarpusN W Lukacs
Jan 20, 1999·The Journal of Experimental Medicine·A CerwenkaR W Dutton
Mar 2, 1999·International Immunology·T ImaiO Yoshie
Jun 26, 1999·European Journal of Immunology·F SallustoA Lanzavecchia
Apr 4, 2000·Nature·L GuB J Rollins
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M J CameronT L Delovitch
Oct 6, 2000·The New England Journal of Medicine·U H von Andrian, C R Mackay
Oct 21, 2000·Journal of Autoimmunity·S BaekkeskovS Kash
Jul 31, 2001·Lancet·M A Atkinson, G S Eisenbarth
Jul 5, 2005·Journal of Diabetes and Its Complications·Carl-David AgardhAke Lernmark
Sep 23, 2008·Clinical and Experimental Immunology·M HedmanR Casas
Oct 10, 2008·The New England Journal of Medicine·Johnny LudvigssonRosaura Casas
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·A AntonelliE Ferrannini
Jun 29, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mikael ChéramyRosaura Casas
Sep 11, 2010·Diabetes/metabolism Research and Reviews·Stina AxelssonRosaura Casas
Jul 1, 2011·Lancet·Diane K WherrettUNKNOWN Type 1 Diabetes TrialNet GAD Study Group
Dec 17, 2011·PloS One·Stina AxelssonRosaura Casas
Feb 3, 2012·The New England Journal of Medicine·Johnny LudvigssonSabine Baron
Citations
Jul 28, 2013·Current Diabetes Reports·Leonard C HarrisonGrant Morahan
Jan 1, 2012·The Review of Diabetic Studies : RDS·Ken T CoppietersMatthias G von Herrath
Mar 16, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ken T CoppietersMatthias G von Herrath
Oct 30, 2013·Human Vaccines & Immunotherapeutics·Anna K E RydénMatthias G Von Herrath
Apr 6, 2020·Diabetologia·Sefina ArifMark Peakman
May 12, 2016·Experimental and Therapeutic Medicine·Cheng LiTang Li
Mar 26, 2019·PloS One·Cristina Vazquez-MateoHans Dooms
Nov 10, 2020·Frontiers in Immunology·Rosaura CasasJohnny Ludvigsson